Presentations

An Evaluation of the Role of Triage Markers for Management of HPV Positive Women Presenting at Colposcopy with Minor Cytological Abnormalities

Tewari P, White C, Kelly L, Kearney P, Pilkington L, D’Arcy T, Murphy C, Anglim M, Farah N, Lee E, Mullen D, Barry O’Crowley J, O’ Toole S, Sharp L, O’Leary JJ

Predictors of anxiety and specific worries after colposcopy within cervical cancer screening: A 12- month longitudinal study

O’Connor M, O’Leary E, Waller J, Gallagher P, Martin CM, O’Leary JJ, D’arcy T, Prendiville W, Flannelly G, Sharp L

Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12 month longitudinal study

O’Connor M, O’Leary E, Waller J, Gallagher P, Martin CM, O’Leary JJ, D’arcy T, Prendiville W, Flannelly G, Sharp L, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Psychological impact of HPV testing in cervical screening

O'Connor M, Murphy J, Costello L, Sharp L

HPV and Non-HPV related Squamous Cell Carcinoma of the Oropharynx

RSR Woods, H Keegan, P Tewari, M Toner, S Kennedy, E O’Regan, C Martin, JJ O’Leary, CV Timon

HPV DNA, mRNA and p16INK4A/Ki-67 protein co-expression in minor cervical abnormalities

White C, Ruttle C, Pilkington L, Bakhiet S, Keegan H, O’Toole S, Spillane C, Sharp L, O’Kelly R, Flannelly G, O’Leary JJ, Martin CM

Assessing the Performance of HPV DNA and mRNA Testing in Colposcopy

P Tewari, C White, L Kelly, P Kearney, H Keegan, L Pilkington, T D’Arcy, C Murphy, M Anglim, S Cleary, N Farah, L Sharpe, O Sheils, S O’ Toole, J O’Leary, C Martin

Cigarette smoking as a risk factor for HPV infection and diagnosis of CIN 2+

White C, Ruttle C, Pilkington L, Keegan H, O’Toole S, Spillane C, Sharp L, O’Kelly R, Flannelly G, O’Leary JJ, Martin CM

Evaluation of the cobas® 4800 HPV test in a population of women referred for colposcopy with abnormal cytology

White C, Keegan H, Pilkington L, Ruttle C, Kerr P, Sharp L, O’Toole S, Turner M, Prendiville W,D’Arcy T, Fitzpatrick M, Flannelly G, O’ Leary J, Martin C

Systems biology derived biomarkers for improved diagnosis of cervical pre-cancer

Kelly L, White C, Bakhiet S, Keegan H, Kehoe L, O’Toole S, JeneyC, JJ O’Leary, Martin C

Reviewing the cost-effectiveness of HPV screening; why we need to include more comparator strategies

O'Mahony et al

Revisiting the simulation evidence for the cost-effectiveness of breast cancer screening of average-risk women

O'Mahony

The cost-effectiveness of HPV screening; reviewing the choice of comparator strategies

O'Mahony et al

Presenting the results of cost-effectiveness analyses of HPV testing in cervical screening in a more intuitive way

O'Mahony

Women's differing experiences of distress following colposcopy and related procedures: a qualitative interview study

O'Connor M, Waller J, Gallagher P, Martin C, O'Leary J, Sharp L

Women's differing experiences of distress following colposcopy and related procedures: a qualitative interview study

O'Connor M, Waller J, Gallagher P, Martin C, O'Leary J, Sharp L

The cost-effectiveness of HPV testing in cervical screening: why current estimates only tell half the story

O'Mahony and Naber

Prevalence of Human Papillomavirus P16ink4a in Multiple Synchronous or Metachronous Primary Squamous Cell Carcinomas of the Upper Aerodigestive Tract

J Kulasegarah, H Keegan, P Tewari, E O’Regan, L Ryan, A Davis, P Kearney, C White, S Kennedy, J O’Leary, M Toner, C Martin, C Timon

Human Papillomavirus DNA and Host Gene mRNA Biomarker Detection in a “Micro Total Analysis System” (microTAS) Device to Aid Diagnosis of Cervical Intraepithelial Neoplasia

Keegan H, Pilkington L, Jordan R, Mozes J, Varga N, Benczik M, Riegger L, Kolta P, Sauer U, Preininger C, Koger B, Brandenburg A, Muller W, Faltin B, Roth G, Martin C, Jeney C, O’Leary JJ

Distress following colposcopy examination for cervical abnormalities: a qualitative study

O'Connor M, Waller J, Gallagher P, Martin C, O'Leary J, Sharp L

Evaluation of the cobas® 4800 HPV test in a population of women referred for colposcopy with abnormal cytology

White C, Keegan H, Pilkington L, Ruttle C, Kerr P, Sharp L, O’Toole S, Turner M, Prendiville W, D’Arcy T, Fitzpatrick M, Flannelly G, O’ Leary J, Martin C.

Assessing the Performance of HPV DNA and mRNA Testing in Colposcopy

P Tewari, C White, L Kelly, P Kearney, H Keegan, L Pilkington, T D’Arcy, C Murphy, M Anglim, S Cleary, N Farah, L Sharpe, O Sheils, S O’ Toole, J O’Leary, C Martin.

Systems biology derived biomarkers for improved diagnosis of cervical pre-cancer

White C, Kelly L, Bakhiet S, Keegan H, Kehoe L, O’Toole S, JeneyC, JJ O’Leary, Martin C.

HPV DNA, mRNA and p16INK4A/Ki-67 protein co-expression in minor cervical abnormalities

White C, Ruttle C, Pilkington L, Bakhiet S, Keegan H, O’Toole S, Spillane C, Sharp L, O’Kelly R, Flannelly G, O’Leary JJ, Martin CM.

Cigarette smoking as a risk factor for HPV infection and diagnosis of CIN 2+

White C, Ruttle C, Pilkington L, Keegan H, O’Toole S, Spillane C, Sharp L, O’Kelly R, Flannelly G, O’Leary JJ, Martin CM.

Evaluating the role of HPV detection assays in the management of women referred to colposcopy

Tewari P, White C, Kelly L, Keegan H, D’Arcy T, Murphy C, Anglim M, Cleary S, Farah N, Sharpe S, Sheils O, Toole O’ S, O’Leary JJ, Martin CM

Prevalence of HPV & p16INK4a multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

Kulasegarah J, Tewari P, Keegan H, O’Regan E, Martin C, O’ Leary J, Davis A, Kennedy S, Toner M, Timon C.

Predictors of HPV knowledge among GPs and practice nurses: results from ATHENS (A Trial of HPV EducatioN and Support)

McSherry L, O’Leary E, Dombrowski S, Francis J, Martin C, O’Leary J, Sharp L

Prevalence and predictors of anxiety and worries in women following colposcopy: results from a longitudinal study

M O'Connor, J Murphy, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville, L Sharp

HPV-related attitudes & behaviours of GPs and practice nurses

McSherry L, Dombrowski S, O’Leary E, Francis J, Murphy J, Martin C, O’Leary J, Sharp L for the ATHENS Group

Prevalence of HPV & p16Ink4a multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

Jeyanthi Kulasegarah, Prerna Tewari, Helen Keegan,Esther O’Regan, Lisa Ryan, Alison Davis, Padraig Kearney, Christine White, Susan Kennedy, John O’Leary, Mary Toner, Cara Martin, Conrad Timon .

Prevalence of HPV & p16INK4a multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

Kulasegarah J, Tewari P, Keegan H, O’Regan E, Martin C, O’ Leary J, Davis A, Kennedy S, Toner M, Timon C.

Assessing the role of a novel panel of mRNA biomarkers for use in managing women in colposcopy

Tewari P Spillane C, Keegan H, Pilkington L, White C, Benczwick M, Varga, N, D’Arcy T, Murphy C, Anglim M, Cleary S, Farah N, Linda Sharpe, Sharon O Toole, Jeney C, O’Leary JJ, Martin CM

The impact of HPV-related attitudes on behaviours of GPs and practice nurses: results from ATHENS (A Trial of HPV EducatioN and Support)

McSherry L, Dombrowski S, Francis J, Martin C, O’Leary J, Sharp L

Associations between psychological and physical after-effects in women undergoing colposcopy and related procedures for follow-up for an abnormal cervical smear

O'Connor M, Murphy J, White C, Ruttle C, Martin C, Flannelly G, von Bunau G, O'Leary J, Pilkington L, Anglim M, Turner M, Farah N, Cleary S, Darcy T, Prendiville W, Sharp L on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Prevalence and predictors of anxiety and worry in women after colposcopy: a longitudinal study

O'Connor M, White C, Ruttle C, Flannelly G, von Bunau G, O'Leary J, Pilkington L, Turner M, Farah N, Cleary S, Darcy T, Prendiville W, Murphy J, Sharp L

Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening: Making Appropriate Comparisons and Usefully Interpreting Results

O’Mahony, Naber, and de Kok

Prevalence of HPV and p16INK4a in multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

Jeyanthi Kulasegarah, Prerna Tewari, Helen Keegan, Esther O’Regan, Lisa Ryan, Alison Davis, Padraig Kearney, Christine White, Susan Kennedy, John O’Leary, Mary Toner, Cara Martin, Conrad Timon

Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening: Appropriate Comparisons and the Useful Interpretations of Results

O'Mahony

Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening: Appropriate Comparisons and the Useful Interpretations of Results

O'Mahony

The Burden of HPV Related Head and Neck Cancer

Jeyanthi Kulasegarah, Helen Keegan, Prerna Tewari, Esther O’Regan, Lisa Ryan, Alison Davis, Padraig Kearney, Christine White, Susan Kennedy, John O’Leary, Mary Toner, Cara Martin, Conrad Timon

Prevalence of HPV & p16INK4a multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

J Kulasegarah, P Tewari, H Keegan, E O’Regan, C Martin, A Davis, S Kennedy, M Toner, C Timon

Prevalence of HPV and outcomes of patients with three or more squamous cell carcinomas of the upper aerodigestive tract

J Kulasegarah, P Tewari, H Keegan, E O’Regan, C Martin, J O’Leary, L Ryan, P Kearney, C White, A Davis, S Kennedy, M Toner, C Timon

“I don’t care what it’s called, I just want to know if I have cancer.” Women’s emotional responses and information needs after having an HPV test

M O'Connor, L Costello, W Prendiville, J Murphy, L Sharp

“I don’t care what it’s called, I just want to know if I have cancer.” Women’s emotional responses and information needs after having an HPV test

M O'Connor, L Costello, W Prendiville, J Murphy, L Sharp

HPV-related attitudes & behaviours of GPs and practice nurses

McSherry L, Dombrowski S, O’Leary E, Francis J, Murphy J, Martin C, O’Leary J, Sharp L for the ATHENS Group

Predictors of HPV knowledge among GPs and practice nurses: results from ATHENS (A Trial of HPV EducatioN and Support)

McSherry L, O’Leary E, Dombrowski S, Francis J, Martin C, O’Leary J, Sharp L

Prevalence and predictors of anxiety and worries in women following colposcopy: results from a longitudinal study

M O'Connor, J Murphy, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville, L Sharp

HPV-related attitudes & behaviours of GPs and practice nurses

McSherry L, Dombrowski S, O’Leary E, Francis J, Murphy J, Martin C, O’Leary J, Sharp L for the ATHENS Group

Prevalence of HPV & p16Ink4a multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

Jeyanthi Kulasegarah, Prerna Tewari, Helen Keegan,Esther O’Regan, Lisa Ryan, Alison Davis, Padraig Kearney, Christine White, Susan Kennedy, John O’Leary, Mary Toner, Cara Martin, Conrad Timon .

Prevalence of HPV & p16INK4a multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

Kulasegarah J, Tewari P, Keegan H, O’Regan E, Martin C, O’ Leary J, Davis A, Kennedy S, Toner M, Timon C.

Assessing the role of a novel panel of mRNA biomarkers for use in managing women in colposcopy

Tewari P Spillane C, Keegan H, Pilkington L, White C, Benczwick M, Varga, N, D’Arcy T, Murphy C, Anglim M, Cleary S, Farah N, Linda Sharpe, Sharon O Toole, Jeney C, O’Leary JJ, Martin CM

Prevalence of multiple synchronous or metachronous primary squamous cell carcinomas of the upper aerodigestive tract

J Kulasegarah, P Tewari, H Keegan, E O’Regan, C Martin, J O’Leary, L Ryan, P Kearney, C White, A Davis, S Kennedy, M Toner, C Timon

Factors associated with never having had a cervical smear: findings from a national population survey

O'Connor M, O'Leary E, Murphy J, Sharp L

HPV-related Attitudes and Behaviours in GPs and Practice Nurses: Preliminary Results of Quantitative Survey from Phase 2 of Athens (A Trial of HPV Education and Support)

McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O'Leary J, Sharp L, for the ATHENS Group

Developing Resources to Support GPs and Practice Nurses in Cervical Screening and HPV: Results of In-Depth Interviews from Phase 1 of Athens (A Trial of HPV Education and Support)

McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O'Leary J, Sharp L, for the ATHENS Group

Assessing the performance of CERVISTA HPV HR TEST in a routine cervical screening population

Keegan H, Pilkington L, O' Brien R, Jamison J, Wilson RT , Carson J, Martin CM, O'Leary JJ

HPV E6/E7 mRNA and HPV DNA testing in post colposcopic treatment surveillance of cervical intraepithelial neoplasia

Pilkington L, Keegan H, White C, Spillane C, O'Toole S, Sheils O, Singh S, Cleary S, Prendiville W, Darcy T, Turner M.J., Von Bunau G, Anglim M, O'Leary J.J., Martin C.M. 

Performance of HPV DNA, E6/E7 mRNA and p16ink4a/Ki-67 protein co-expression as a triage tool for LSIL/ASCUS

White C, Ruttle C, Pilkington L, Bakhiet S, Keegan H, O'Toole S, Spillane C, Sharp, L, O'Kelly R, Flannelly G, O'Leary JJ, Martin CM

The efficacy of HPV E6/7 mRNA testing in post colposcopic treatment surveillance of cervical intraepithelial neoplasia

L. Pilkington, H. Keegan, C. White, C. Spillane, S. O'Toole, O. Sheils, S. Singh, S. Cleary, W. Prendiville, T. Darcy, M.J. Turner, G. Von Bunau, M. Anglim, J.J. O'Leary, C.M. Martin

HPV infection and p16ink4a/Ki-67 co-expression in low grade cervical abnormalities

White C, Ruttle C, Pilkington L, Keegan H, O'Toole S, Spillane C, Sharp L, O'Kelly R, Flannelly G, O'Leary JJ, Martin CM

What do women who have never had a smear test think? Women's Attitudes and beliefs and other factors associated with never having had a smear

Sharp L, O'Connor M, Murphy J, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

"Well I don't care what it's called, I don't care whether it's HPV or ABC, I just want to know if I have cancer." Women's emotional reactions and information needs after undergoing an HPV test

O'Connor M, Costello L, Murphy JC, Hayes Jordan D, Murphy J, Bastick P, Farrar K, Martin M, Prendiville W, Sharp L, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Inter-relationships between psychological and physical after-effects reported by women undergoing colposcopy and related procedures

O'Connor M, Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Developing an intervention to support primary care practitioners in their HPV-related clinical practice: findings from in-depth interviews

McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O’Leary J, Sharp L for the ATHENS Group

A Comparison of the ThinPrep Imaging System and Manual Screening by Meta Analysis and Systematic Review

Kingston D, Lordan G, Griffin M, Gibbons D, Bolger, Nuttall D S, Pilkington L4, Bennett K, Martin C M, O'Leary J J, Normand C

The clinical utility of HPV status and p16INK4A/Ki-67 as a triage tool for low grade cervical disease

White C, Ruttle C, Pilkington L, McInerney J, Keegan H, O'Toole S, Spillane C, O'Kelly R, Flannelly G, Fitzpatrick M, Lenehan P, O'Leary J, Martin C

ATHENS (A Trial of HPV Education and Support): Phase 1- results of in-depth interviews

McSherry L, Murphy J, Dombrowski S, Francis J, Martin C, O’Leary J, Sharp L for the ATHENS Group

Psychological impact of colposcopy among women being followed-up for abnormal cervical smears: prevalence of worries, anxiety and depression at 4 months

M O'Connor, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville J Murphy, L Sharp on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from the ATHENS trial

McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O’Leary J, Sharp L for the ATHENS Group

The psychological cost of screening women for cervical cancer in Ireland

M O'Connor, J Murphy, L Sharp

Attitudes of women and mothers towards HPV vaccination in Ireland: findings from a national population survey

M O'Connor, Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

How can uptake of cervical screening be increased? Comparisions of characteristics, attitudes, and beliefs of women who have had, or never had, a smear test

M O'Connor, Murphy J, Sharp L, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Barriers to accessing information and factors that impact on women's HPV information needs: implications for cervical screening programmes

O'Connor M, Costello L, Murphy JC, Hayes Jordan D, Murphy J, Bastick P, Farrar K, Martin M, Prendiville W, Sharp L, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Post-colposcopy psychological effects at 4 months: A study of women in Ireland

J Murphy, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville, M O'Connor, L Sharp on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Women's experience and views of HPV testing: a qualitative study of the impact of HPV testing on women

M O'Connor, L Costello, J Murphy, W Prendiville, L Sharp on behalf of CERVIVA with the staff at the AMNCH colposcopy clinic

Comparison of HPV DNA detection technologies; Hybrid capture II (Qiagen) and Cervista™ HPV HR (Hologic UK Ltd

Keegan H , Pilkington L , O' Brien R, Jamieson J, Wilson RT, Carson J, Martin CM ,O'Leary JJ

Biomarkers and HR-HPV results in high precision screening diagnosis

Jeney C, Mózes J, Varga N, Benczik M, Kovács A, Kaltenecker B, Lukács A, Babarczi E, Koiss R, Keegan H, Pilkington L, Spillane C, Martin CM, O'Leary JJ

Psychological after-effects of colposcopy: prevalence of worries, anxiety and depression at 4 months

M O'Connor, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville J Murphy, L Sharp on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from the ATHENS study

McSherry LA, S Dombrowski, J Francis, J Murphy, C Martin, J O’Leary, L Sharp for the ATHENS group

HPV E6/7 mRNA and HPV DNA testing in post colposcopic treatment surveillance of cervical intraepithelial neoplasia

L. Pilkington, H. Keegan, C. White, C. Spillane, S. O'Toole, O. Sheils, S. Singh, S. Cleary, W. Prendiville, T. Darcy, M.J. Turner, G. Von Bunau, M. Anglim, J.J. O'Leary, C.M. Martin

Women's views of HPV vaccination in Ireland: findings from a national population survey

O'Connor M, Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Developing resources to support primary care health professionals in cervical screening and HPV: Preliminary results from ATHENS

McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O'Leary J, Sharp L for the ATHENS Group

Comparison of Hybrid Capture 2 (Qiagen), Full-Spectrum HPV (GenoID), GenoID Molecular Beacon real-time HPV Assay with genotyping by Linear Array (Roche) in an Irish colposcopy population

Keegan H, Pilkington L, Mc Inerney J, Pal-Szenthe B, Benczik M, Kaltenecker B, Mózes J, Kovács A and Solt A, Bolger N, Jeney C, O'Leary JJ, Martin CM

Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from semi-structured interviews in the ATHENS study

McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O'Leary J, Sharp L for the ATHENS Group

Women's knowledge and views about HPV infection and vaccination: findings from a national population survey in Ireland

O'Connor M, J Murphy, L Sharp, C Martin, L Pilkington, O Sheils, J O'Leary, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Women's knowledge and views about HPV infection and vaccination: findings from a national population survey in Ireland

O'Connor M, J Murphy, L Sharp, C Martin, L Pilkington, O Sheils, J O'Leary, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Comparison of HPV detection technologies; Hybrid Capture2 (Qiagen), Full-spectrum HPV (GenoID), GenoID Molecular Beacon Real-Time HPV Assay with genotyping by Linear array (Roche) and GenoID HPV ELISA genotyping assay in an Irish colposcopy population

Keegan H Pilkington L, Mc Inerney J, Pal-Szenthe B, Benczik M, Kaltenecker B, Mózes J, Kovács A and Solt A, Bolger N, Jeney C, O'Leary JJ, Martin CM

The utility of HPV testing in predicting disease recurrence post colposcopic treatment for cervical intraepithelial neoplasia

Pilkington L, Keegan H, O'Toole S, Singh S, Cleary S, Prendiville W, Darcy T, Turner MJ,, Von Bunau G, Anglim M, O'Leary JJ, Martin CM

Comparison of HPV DNA detection technologies: Hybrid capture II (Qiagen), Cervista™ HPV HR (Hologic UK Ltd) in a Northern Irish Screening Population.) in a Northern Irish Screening Population

Keegan H, Pilkington L, Jamison J, Wilson R, Carson J, Martin CM, O'Leary JJ

The NSAID Sulindac inhibits proliferation and induces apoptosis in cervical cell lines

Spillane CD, White C, Kehoe L, Sheils O, Martin CM, O'Leary JJ

Comparison of HPV detection technologies; Hybrid Capture2 (Qiagen), Full-spectrum HPV (GenoID), GenoID Molecular Beacon Real-Time HPV Assay with genotyping by Linear array (Roche) and GenoID HPV ELISA genotyping assay in an Irish colposcopy population

Keegan H Pilkington L, Mc Inerney J, Pal-Szenthe B, Benczik M, Kaltenecker B, Mózes J, Kovács A and Solt A, Bolger N, Jeney C, O'Leary JJ, Martin CM.

The utility of HPV testing in predicting disease recurrence post colposcopic treatment for cervical intraepithelial neoplasia

Pilkington L, Keegan H, O'Toole S, Singh S, Cleary S, Prendiville W, Darcy T, Turner MJ,, Von Bunau G, Anglim M, O'Leary JJ, Martin CM.

HPV DNA/mRNA testing and smoking as a risk factor in predicting high grade cervical disease in women presenting with low grade cervical lesions

White C, Ruttle C, Pilkington L, McInerney J, Keegan H, O'Toole S, Spillane C, Sharp, L, O'Kelly R, Fitzpatrick M, Lenehan P, Flannelly G, O'Leary J, Martin CM

HPV DNA/mRNA testing and smoking as a risk factor in predicting high grade cervical disease in women presenting with low grade cervical lesions

White C, Ruttle C, Pilkington L, McInerney J, Keegan H, O'Toole S, Spillane C, Sharp, L, O'Kelly R, Fitzpatrick M, Lenehan P, Flannelly G, O'Leary J, Martin CM.

Comparison of HPV DNA and mRNA testing in women presenting to colposcopy with low grade cervical abnormalities

White C, Ruttle C, Pilkington L, McInerney J, Keegan H, O'Toole S, Spillane C, Sharp, L, O'Kelly R, Fitzpatrick M, Lenehan P, Flannelly G, O'Leary J, Martin CM

A novel expression biomarker set has high accuracy to predict CIN1+ lesions using routine cervical cytology specimens

Jeney C, Mózes J, Varga N, Benczik M, Kovács A, Kaltenecker B, Szenthe B, Takács T, Kurucz M, Lukács A, Keegan H, Pilkington L, Spillane CD, Martin CM, J. O'Leary JJ

Significance of HPV mRNA testing and cigarette smoking in risk assessment for high grade cervical disease

White C, Ruttle C, Pilkington L, Flannelly G, O'Leary JJ, Martin CM

HPV prevalence and persistence in a cohort of HIV positive women in Ireland

Mc Inerney J, H Keegan, L Pilkington, A Loy, C White, S Delamere, F Karlsen O Sheils, CM Martin, F Mulcahy and JJ O' Leary

The NSAID Sulindac inhibits proliferation and induces apoptosis in cervical cancer cell lines

Spillane CD, White C, Linder K, McEligott T, Kehoe L, Sheils O, Martin CM, O'Leary JJ

Comparison of HPV DNA detection technologies: Hybrid capture II (Qiagen), Cervista™ HPV HR (Hologic UK Ltd) in a Northern Irish Screening Population

O'Leary, JJ Keegan H, Pilkington L, Jamison J, Wilson R, Carson J, Martin CM

Lab-on-a-Chip: The Future of Cervical Pre-Cancer Diagnostics

H Keegan, T Baier, T Hansen-Hagge, F Karlsen, A Gullicksen, P Gronn, L Solli, M Mielnik, L Furuberg, P Koltay, L Riegger, N Bolger, JJ O'Leary, CM Martin

Human papillomavirus DNA and mRNA prevalence and persistence in human immunodeficency virus positive women

Mc Inerney J, Keegan H, Pilkington, L, Sheils O, Martin C.M., Loy A, Delamere S, Barrett M, Griffin M, Lyons F, Mulcahy F, O'Leary JJ. 

Human Papillomavirus DNA and mRNA Prevalence and Persistence in a Cohort of Human Immunodeficency Virus Positive Women in Ireland

J Mc Inerney, H Keegan, L Pilkington, O Sheils, CM Martin, A Loy, S Delamere, M Barrett, M Griffin, F Lyons, F Mulcahy, JJ O'Leary

Comparison of HPV detection technologies; Hybrid Capture 2 (Qiagen), full-spectrum HPV (Genoid), Genoid Molecular Beacon Real-Time HPV assay with genotyping by Linear Array (Roche) and Genoid HPV Elisa Genotyping Assay in an Irish colposcopy population

Keegan H, Pilkington L, Mc Inerney J, Pal-Szenthe B, Benczik M, Kaltenecker B, Mózes J, Kovács A, Solt A, Bolger N, Jeney C, O'Leary JJ, Martin CM

Comparison of HPV DNA detection technologies; Hybrid Capture 2 (Qiagen), Cervista™ (Hologic UK Ltd) in a Northern Irish screening population

Keegan H, Pilkington L, Jamieson J, Wilson RT, Carson J, Martin CM, O'Leary JJ

Comparison of HPV DNA detection technologies; Hybrid Capture 2 (Qiagen), Cervista™ (Hologic UK Ltd) in a Northern Irish screening population

Keegan H, Pilkington L, Jamieson J, Wilson RT, Carson J, Martin CM, O'Leary JJ

NSAID, sulindac, inhibits proliferation and induces apoptosis in cervical cancer cells

CD Spillane, L Kehoe, O Sheils, CM Martin and JJ O'Leary

Human papillomavirus DNA and mRNA prevalence and persistence in human immunodeficency virus positive women

Mc Inerney J, Keegan H, Pilkington, L, Sheils O, Martin C.M., Loy A, Delamere S, Barrett M, Griffin M, Lyons F, Mulcahy F, O'Leary JJ. 

Transcriptome analysis of oncogene silenced HPV 16 positive carcinoma cells

Spillane CD,Kehoe L, Sheils O, Martin CM, O'Leary JJ

Lab-on-a-Chip: The Future of Cervical Pre-Cancer Diagnostics

H Keegan, T Baier, T Hansen-Hagge, F Karlsen, A Gullicksen, P Gronn, L Solli, M Mielnik, L Furuberg, P Koltay, L Riegger, N Bolger, JJ O'Leary, CM Martin.

Human Papillomavirus DNA and mRNA Prevalence and Persistence in a Cohort of Human Immunodeficency Virus Positive Women in Ireland

J Mc Inerney, H Keegan, L Pilkington, O Sheils, CM Martin, A Loy, S Delamere, M Barrett, M Griffin, F Lyons, F Mulcahy, JJ O'Leary.

miRNA Profiling in Cervical Cancer

L Kehoe, CD Spillane, M Gallagher, O Sheils, C Martin, JJ O'Leary.

miRNA Profiling in Cervical Cancer

L Kehoe, CD Spillane, M Gallagher, O Sheils, C Martin, JJ O'Leary.

Investigation of the p16[INK4A] Pathway

L Kehoe, CD Spillane, M Gallagher, O Sheils, C Martin, JJ O'Leary.

miRNA Profiling in Cervical Cancer

Kehoe L, Spillane CD, Gallagher M, Sheils O, Martin C, O'Leary JJ

Lab on a chip: the future of cervical pre-cancer diagnostics

Keegan H, Baier T, Hansen-Hagge T, Karlsen F, Gullicksen A, Gronn P, Solli L, Mielnik M, Furuberg L, Koltay P, Riegger L, Bolger N, O'Leary JJ, Martin CM

Investigation of the p16[INK4A] Pathway

Kehoe L, Spillane CD, Gallagher M, Sheils O, Martin C, O'Leary JJ

Comparison of HPV DNA detetion technologies: Hybrid capture II (Qiagen), Cervista™ HPV HR (Hologic UK Ltd) in a Northern Irish Screening Population

Keegan H, Pilkington L, Jamison J, Wilson R, Carson J, Martin CM, O'Leary JJ

Comparison of HPV DNA detetion technologies: Hybrid capture II (Qiagen), Cervista™ HPV HR (Hologic UK Ltd) in a Northern Irish Screening Population

Keegan H, Pilkington L, Jamison J, Wilson R, Carson J, Martin CM, O'Leary JJ.

"Prevalence and persistence of integrated oncogenic HPV in HIV positive women

Loy A, McInerney J, Delamere S, Keegan H, Pilkington L, Sheils O, Lyons F, Martin C, J O' Leary JJ, and Mulcahy F

Molecular Pathology - impact on future diagnosis

O'Leary JJ

Irish women's views on cervical screening, HPV infection and HPV vaccination

Murphy J, Sharp L, Martin C, Sheils O, Pilkington L, O'Leary J

Biomarkers in cervical cancer

O'Leary JJ

Predicting disease recurrence using HPV testing post colposcopic treatment for cervical intraepithelial neoplasia. CERVIVA; An interim report

Singh S, Martin CM, Pilkington L, O'Toole S, Keegan H, Cleary S, Prendiville W, Darcy T. M.J. Turner MJ, O'Leary JJ

High throughput HPV screening using a one step multiplex real-time PCR based system

Jeney C, Sebe A, Szenthe B, Kovacs A, Kaltenecker B, Benczik M, Keegan H, Martin C, O'Leary J, Takacs T

Human papillomavirus prevalence and genotype distribution in Irish women attending routine cervical screening

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Casey M, Sheils O, O'Leary JJ, Martin CM

High throughput HPV screening using a one step multiplex real-time PCR based system

Jeney C, Sebe A, Szenthe B, Kovacs A, Kaltenecker B, Benczik M, Keegan H, Martin C, O'Leary J, Takacs T

The prevalence and persistence of human papillomavirus in human immunodeficiency virus positive women

Mc Inerney J, Keegan H, Pilkington, L, C. Ni Cheallaigh, S. Delamere, M. Griffin, G. McHugh, P. Webster, M. Barrett, F. Lyons, C. Bergin, F. Mulcahy, S. Clarke, Sheils O, O'Leary JJ, Martin C.M

Lab on a chip: The future of cervical pre-cancer diagnostics

Keegan H, Baier T, Hansen-Hagge T, Karlsen F, Gullicksen A, Gronn P, Solli L, Mielnik M, Furuberg L, Koltay P, Riegger L, Bolger N, O'Leary JJ, Martin CM.

The prevalence and persistence of human papillomavirus in human immunodeficiency virus positive women

Mc Inerney J, Keegan H, Pilkington L, Ni Cheallaigh C, Delamere S, Griffin M, McHugh G, Webster P, Barrett M, Lyons F, Bergin C, Mulcahy F, Clarke S, Sheils O, O'Leary JJ, Martin CM.

Human papillomavirus prevalence and genotype distribution in Irish women attending routine cervical screening

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Casey M, Sheils O, O'Leary JJ, Martin CM.

Lab on a chip: The future of cervical pre-cancer diagnostics

Keegan H, Baier T, Hansen-Hagge T, Karlsen F, Gullicksen A, Gronn P, Solli L, Mielnik M, Furuberg L, Koltay P, Riegger L, Bolger N, O'Leary JJ, Martin CM.

Towards point of care chip based diagnostics based on mRNA

Baier T, Furuberg L, Hansen-Hagge T, Gransee R, Crombé A, Solli L, Gulliksen A, Martin C, Keegan H, Riegger L, Mielnik M, O'Leary JJ, Karlsen F

Towards automatic chip-based detection of HPV mRNA in cervical samples

Baier T, Hansen-Hagge T, Gransee R, Crombé A, Solli L, Gulliksen A, Martin C, Keegan H, O'Leary JJ, Riegger L, Mielnik M, Furuberg L

Functional inactivation of HPV transforming genes: new insights into cervical cancer

O'Leary JJ

Silencing of HPV viral oncogenes E6 and E7 in cervical cancer

Spillane CD, Kehoe L, Sheils O, Martin CM, O'Leary JJ.

Prevalence and genotype distribution of Human Papillomavirus in the Irish cervical screening population

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Casey M, Sheils O, O'Leary JJ, Martin CM

What are women's views on cervical screening and HPV vaccination? A qualitative study in Ireland EUROGIN conference 2008: Joining forces for cervical cancer prevention

Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Human papillomavirus prevalence and persistence, in the cervix of women with human immunodeficiency virus

Martin CM, Mc Inerney J, Keegan H, Pilkington L, Ni Cheallaigh C, Delamere S, Griffin M, McHugh G, Webster P, Barrett M, Lyons F, Bergin C, Mulcahy F, Clarke S, Sheils O, O'Leary JJ

Prevalence and genotype distribution of Human Papilloma Virus in the Irish Cervical Screening Population

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Casey M, Sheils O, O'Leary JJ, Martin CM

Elucidation of the role of the p16INK4A pathway in the cell cycle and its relationship with the Human Papilloma Virus in cervical cancer

Kehoe L, Spillane CD, Martin C, O'Leary JJ

Development of automatic chip-based detection of mRNA

Solli L, Gullicksen A, Baier T, Gransee R, Hansen-Hagge T, Mielnik M, Johansen I-R, Furuberg L, Rigger L, Koltay P, Martin C, Keegan H, O'Leary J, Karlsen F et al

A focus group study in Ireland of women's views, attitudes and knowledge of cervical screening and Human Papillomavirus (HPV)

Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Human papillomavirus prevalence and genotype distribution in the Irish cervical screening population. Findings from a qualitative focus group study

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Sheils O, O'Leary JJ, Martin C

Women's knowledge and attitudes regarding cervical screening and human papillomavirus (HPV): Focus group findings from Ireland

Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Women's knowledge and attitudes regarding cervical screening and human papillomavirus (HPV): Focus group findings from Ireland

Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Human papillomavirus prevalence and genotype distribution in the Irish cervical screening population. Findings from a qualitative focus group study

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Sheils O, O'Leary JJ, Martin C

Comparison of PreTect? HPV-Proofer and Hybrid Capture 2 for HPV detection with viral load analysis of HPV16, HPV18 and HPV33 E6/E7mRNA positive specimens

Keegan H, Mc Inerney J, Pilkington L, Gronn P, Silva I, Karlsen F, Bolger N, Logan C, Furuberg L, O'Leary JJ, Martin CM

Evaluation of HPV DNA and mRNA detection technologies for detecting HPV in cervical cytology specimens

Keegan H, Mc Inerney J, Pilkington L, Gronn P, Silva I, Karlsen F, Bolger N, O'Leary JJ, Martin CM.

Evaluation of HPV DNA and mRNA Detection Technologies for Detecting HPV in Cervical Cytology Specimens

Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, O'Leary JJ, Martin CM.

GPs' knowledge of HPV infection and vaccination: Is there a need for further professional education

Murphy J, Sharp L, Carsin AE

Irish women's attitudes & knowledge of cervical screening & human papillomavirus (HPV): Preliminary findings from a focus group study

Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)

Oncogenic HPV sustypes in HIV-positive women

Ni Cheallaigh C, Sheils O, Griffiths S, Webster P, Martin C, McInerney J, Keegan H, O'Leary J, Lyons F, Bergin C, Mulcahy F, Clarke S

HPV infection, testing and vaccination: knowledge, attitudes and practices among GPs

Murphy J, Sharp L, Carsin AE

Human papillomavirus prevalence and persistence, in the cervix of women with human immunodeficiency virus

Martin CM Mc Inerney J, Keegan H1, Pilkington, L1, C Ni Cheallaigh, S Delamere, M Griffin, G McHugh, P Webster, M Barrett, F Lyons, C Bergin, F Mulcahy, S Clarke, Sheils O, O'Leary JJ.

Prevalence and genotype distribution of Human Papillomavirus in the Irish cervical screening population

Mc Inerney J, Pilkington L, Keegan H, Ring M, Bolger N, Casey M, Sheils O, O'Leary JJ, Martin CM.

Attitudes and knowledge of GPs towards HPV infection, testing and vaccination: results from a national survey in Ireland

Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA).

A Comparison of the Thin Prep Imaging System and Manual Screening by Meta Analysis and Systematic Review

Normand C

Development of a virtual web based external quality assessment (EQA) scheme in Cytopathology

O'Shea D Doolan C, Bolger N, Cullen R, Pilkington L, Martin C, Magee D, Griffin M, Gibbons D, O'Leary JJ

Villoglandular Adenocarcinoma of the cervix: High Risk HPV infection is associated with disruption of DNA licensing and replisome proteins

Kehoe L, Ring M, Pilkington L, Keegan H, Astbury K, Sheils O, Griffin M, Gaffney E, Gibbons D, Martin CM, O'Leary JJ

Development of a virtual web based external quality assessment (EQA) scheme in Cytopathology

O'Shea D Doolan C, Bolger N, Cullen R, Pilkington L, Martin C, Magee D, Griffin M, Gibbons D, O'Leary JJ.

Human Papilloma Virus prevalence and genotype distribution in the Irish cervical screening population

McInerney J, Pilkington L, Keegan H, Ring M, Bolger N, Sheils O, O'Leary J, Martin CM

Silencing of HPV Viral Oncogenes E6 and E7 in Cervical Cancer

Spillane CD, Kehoe L, Keegan H, Sheils O, Martin CM, O'Leary JJ

Evaluation of HPV DNA and mRNA Detection Technologies for Detecting HPV in Cervical Cytology Specimens

Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, O'Leary JJ, Martin CM

Comparison of HPV Detection technologies; Hybrid Capture II (Digene), Pretect HPV Proofer (Norchip) and Real time PCR for Detection of HPV in cervical cytology specimens

Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, O'Leary JJ, Martin CM

Comparison of HPV Detection technologies; Hybrid Capture II (Digene), Pretect HPV Proofer (Norchip) and Real time PCR for Detection of HPV in cervical cytology specimens

Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, O'Leary JJ, Martin CM

HPV DNA and mRNA testing in the Irish Cervical Screening Population

Martin, CM

GPs' views on screening for cervical cancer and HPV testing: results from a national survey in Ireland

Murphy J, Sharp L, Carsin AE

Cancer, Genes, Proteins and Stemness

O'Leary JJ

MicroRNA signatures in Cervical Cancer: suggests hierarchical miRNA control of gene expression

Martin C, Astbury K, Becker C, Henfrey R, Sherlock J, Guenther S, Sheils O, O'Leary JJ

Significant dysregulation of DNA replication license and replisome proteins in villoglandular carcinomas of the cervix indicates possible aggressive biological behaviour

Ring M, Crowther S, Martin C, Astbury K, Sheils O, Griffin M, Gaffney E, Gibbons D, O'Leary JJ

miRNA Expression Signatures in Cervical Cancer

Martin CM, Astbury K, Henfrey R, Sheils O, Gallagher M, Heffron C, Logan C, O'Leary JJ.

Identification of Cell Cycle Regulatory Molecules as Biomarkers in Cervical Cancer using Gene Expression Profiling

Astbury K, Martin CM, Smyth P, O'Leary JJ

miRNA Expression Signatures in Cervical Cancer

Martin CM, Astbury K, Henfrey R, Sheils O, Gallagher M, Heffron C, Logan C, O'Leary JJ

Significance of HPV mRNA testing and cigarette smoking in risk assessment for high grade cervical disease

White C, Ruttle C, Pilkington L, Flannelly G, O'Leary JJ, Martin CM.

Significance of HPV mRNA testing and cigarette smoking in risk assessment for high grade cervical disease

White C, Ruttle C, Pilkington L, McInerney J, Keegan H, O' Donnell A, Stapleton M, Flannelly G, O'Leary JJ, Martin CM.